2
RESEARCH METHODOLOGY
29
5
MARKET OVERVIEW
Emerging economies and tech advancements drive vascular imaging growth amid cost and skill challenges.
48
5.2.1.1
RISING PREVALENCE OF CARDIOVASCULAR DISEASES
5.2.1.2
GROWING INCLINATION TOWARD MINIMALLY INVASIVE AND PERSONALIZED INTERVENTIONS
5.2.1.3
TECHNOLOGICAL ADVANCEMENTS IN VASCULAR IMAGING SYSTEMS
5.2.1.4
INCREASING INVESTMENTS, FUNDS, AND GRANTS BY PUBLIC-PRIVATE ORGANIZATIONS
5.2.2.1
HIGH COST AND RESOURCE REQUIREMENTS
5.2.2.2
RADIATION EXPOSURE AND CONTRAST-RELATED RISKS
5.2.2.3
UNFAVORABLE REIMBURSEMENT SCENARIO
5.2.3.1
HIGH GROWTH POTENTIAL IN EMERGING ECONOMIES
5.2.3.2
INCREASING ESTABLISHMENT OF HOSPITALS AND DIAGNOSTIC IMAGING CENTERS
5.2.3.3
RISING ADOPTION OF TELERADIOLOGY
5.2.4.1
NEED TO MAINTAIN HIGH-QUALITY, ARTIFACT-FREE IMAGES
5.2.4.2
HOSPITAL BUDGET CUTS
5.2.4.3
INCREASING ADOPTION OF REFURBISHED VASCULAR IMAGING SYSTEMS
5.2.4.4
DEARTH OF TRAINED PROFESSIONALS
5.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
5.5
STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
6
INDUSTRY TRENDS
Uncover strategic insights with detailed industry forces and evolving global healthcare trends analysis.
59
6.1
PORTER’S FIVE FORCES ANALYSIS
6.1.1
BARGAINING POWER OF BUYERS
6.1.2
BARGAINING POWER OF SUPPLIERS
6.1.3
THREAT OF NEW ENTRANTS
6.1.4
THREAT OF SUBSTITUTES
6.1.5
INTENSITY OF COMPETITIVE RIVALRY
6.2
MACROECONOMIC INDICATORS
6.2.2
GDP TRENDS AND FORECAST
6.2.3
TRENDS IN GLOBAL ENVIRONMENTAL INDUSTRY
6.2.4
TRENDS IN GLOBAL HEALTHCARE INDUSTRY
6.3
SUPPLY CHAIN ANALYSIS
6.3.1
PROMINENT COMPANIES
6.3.2
SMALL & MEDIUM-SIZED ENTERPRISES
6.4.1
RESEARCH & DEVELOPMENT
6.4.2
RAW MATERIAL PROCUREMENT
6.4.3
MANUFACTURING & ASSEMBLY
6.4.4
DISTRIBUTION, MARKETING & SALES, AND POST-SALE SERVICES
6.7.1
TRADE DATA FOR COMPUTED TOMOGRAPHY SYSTEMS (HS CODE 902212)
6.7.2
TRADE ANALYSIS FOR ULTRASOUND SYSTEMS (HS CODE 901812)
6.7.3
TRADE ANALYSIS FOR MAGNETIC RESONANCE IMAGING SYSTEMS (HS CODE 901813)
6.7.4
TRADE ANALYSIS FOR X-RAY SYSTEMS (HS CODE 902214)
6.8
KEY CONFERENCES AND EVENTS, 2025–2026
6.9
TRENDS IMPACTING CUSTOMERS’ BUSINESSES
6.10
INVESTMENT AND FUNDING SCENARIO
6.12
IMPACT OF 2025 US TARIFF
6.12.3
PRICE IMPACT ANALYSIS
6.12.4
IMPACT ON COUNTRY/REGION
6.12.5
IMPACT ON END-USE INDUSTRIES
7
STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTION
AI-driven imaging technologies redefine precision and efficiency in the vascular imaging market.
82
7.1
KEY EMERGING TECHNOLOGIES
7.1.1
MAGNETIC RESONANCE IMAGING (MRI)
7.1.2
COMPUTED TOMOGRAPHY (CT)
7.2
COMPLEMENTARY TECHNOLOGIES
7.2.1
PICTURE ARCHIVING AND COMMUNICATION SYSTEMS (PACS)
7.2.2
ARTIFICIAL INTELLIGENCE (AI) FOR IMAGE ANALYSIS
7.4
IMPACT OF AI ON VASCULAR IMAGING MARKET
7.4.2
TOP USE CASES AND MARKET POTENTIAL
7.4.3
BEST PRACTICES IN VASCULAR IMAGING MARKET
7.4.4
CASE STUDY ON AI IMPLEMENTATION IN VASCULAR IMAGING MARKET
7.4.5
CLIENTS' READINESS TO ADOPT GENERATIVE AI IN THE VASCULAR IMAGING MARKET
7.5
SUCCESS STORIES AND REAL-WORLD APPLICATIONS
8
REGULATORY LANDSCAPE
Navigate complex global regulations with insights into compliance, stakeholder influence, and unmet market needs.
92
8.1
REGULATIONS AND COMPLIANCE
8.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
8.3
CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
8.3.1
DECISION-MAKING PROCESS
8.4
KEY STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.4.1
KEY STAKEHOLDERS IN BUYING PROCESS
8.5
ADOPTION BARRIERS AND INTERNAL CHALLENGES
8.6
UNMET NEEDS FROM VARIOUS END-USE CUSTOMERS
9
VASCULAR IMAGING MARKET, BY PRODUCT TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 17 Data Tables
101
9.2.1.1
DUPLEX ULTRASOUND
9.2.1.2
DOPPLER ULTRASOUND
9.2.2.1
GROWING ADOPTION OF NON-INVASIVE DIAGNOSTIC TECHNIQUES TO FUEL MARKET
9.2.3.1
HIGH SPATIAL RESOLUTION AND REAL-TIME IMAGING ABILITY TO BOOST MARKET
9.2.4
NUCLEAR IMAGING SYSTEMS
9.2.4.1
INCREASING ADVANCEMENTS IN HYBRID IMAGING SYSTEMS TO FACILITATE GROWTH
9.2.5.1
WIDE APPLICABILITY OF CT IN DIAGNOSING VASCULAR ABNORMALITIES TO FAVOR GROWTH
9.2.6
OPTICAL COHERENCE TOMOGRAPHY
9.2.6.1
ABILITY TO PROVIDE MICRON-LEVEL RESOLUTION TO SUPPORT GROWTH
9.2.7
OTHER SYSTEMS & CONSOLES
9.3
ACCESSORIES & CONSUMABLES
9.3.1
NEED FOR CONSISTENT IMAGE QUALITY AND PATIENT SAFETY TO FOSTER GROWTH
9.4.1.1
RISING FOCUS ON EARLY DETECTION OF VASCULAR DISEASES TO AID GROWTH
9.4.2
HIGH SPATIAL AND TEMPORAL RESOLUTION
9.4.2.1
INCREASING PRODUCT DEVELOPMENT TO FACILITATE GROWTH
9.4.3
AUTOMATED VESSEL MORPHOLOGY ASSESSMENT
9.4.3.1
NEED FOR PRECISE AND REPRODUCIBLE ANALYSIS TO EXPEDITE GROWTH
9.4.4
STREAMLINED PROCEDURAL WORKFLOW
9.4.4.1
RISING PATIENT VOLUME TO CONTRIBUTE TO GROWTH
9.4.5
OTHER SOFTWARE & SERVICES
10
VASCULAR IMAGING MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 7 Data Tables
115
10.2.1
GROWING GLOBAL BURDEN OF CARDIOVASCULAR DISEASES TO DRIVE MARKET
10.3.1
EXPANDING ACCESS TO DIAGNOSTIC FACILITIES TO BOOST MARKET
10.4.1
GROWING INCIDENCE OF AUTOIMMUNE AND INFLAMMATORY DISORDERS TO PROPEL MARKET
10.5
DEEP VEIN THROMBOSIS
10.5.1
INCREASING FOCUS ON PREVENTIVE HEALTHCARE AND TECHNOLOGICAL INNOVATIONS TO PROMOTE GROWTH
10.6
ARTERIOVENOUS MALFORMATIONS & FISTULAS
10.6.1
RISING USE OF MINIMALLY INVASIVE ENDOVASCULAR THERAPIES TO EXPEDITE GROWTH
11
VASCULAR IMAGING MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 5 Data Tables
121
11.2.1
STRONG REIMBURSEMENT FRAMEWORKS AND GOVERNMENT SUPPORT FOR MODERNIZING HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET
11.3
DIAGNOSTIC IMAGING CENTERS
11.3.1
INCREASING FOCUS ON OUTPATIENT CARE AND PREVENTIVE DIAGNOSTICS TO ENCOURAGE GROWTH
11.4
AMBULATORY SURGERY CENTERS
11.4.1
GROWING EMPHASIS ON VALUE-BASED CARE TO PROPEL MARKET
12
VASCULAR IMAGING MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 14 Countries | 100 Data Tables.
127
12.2.1
NORTH AMERICA: MACROECONOMIC OUTLOOK
12.2.2.1
HIGH PREVALENCE OF CHRONIC VASCULAR DISEASES TO DRIVE MARKET
12.2.3.1
RAPIDLY AGING POPULATION TO SUPPORT GROWTH
12.3.1
EUROPE: MACROECONOMIC OUTLOOK
12.3.2.1
HIGH NUMBER OF MRI AND CT UNITS TO FUEL MARKET
12.3.3.1
INCREASING INVESTMENTS IN IMAGING INFRASTRUCTURE TO DRIVE MARKET
12.3.4.1
INCREASING FOCUS ON EARLY DETECTION OF VASCULAR DISORDERS AND STRONG TECHNOLOGICAL ADOPTION TO BOOST MARKET
12.3.5.1
DEMOGRAPHIC SHIFT TOWARD AGING POPULATION AND INCREASING FOCUS ON NON-INVASIVE DIAGNOSTIC SOLUTIONS TO AID GROWTH
12.3.6.1
GROWING ACCESS TO ADVANCED CANCER VASCULAR TO PROPEL MARKET
12.4.1
ASIA PACIFIC: MACROECONOMIC OUTLOOK
12.4.2.1
PRESENCE OF UNIVERSAL HEALTHCARE COVERAGE TO FUEL MARKET
12.4.3.1
FAVORABLE GOVERNMENT INITIATIVES AND DEMOGRAPHIC SHIFT TO AID GROWTH
12.4.4.1
INCREASING NUMBER OF VASCULAR PROCEDURES AND PUBLIC & PRIVATE INVESTMENTS TO PROMOTE GROWTH
12.4.5.1
GROWING AWARENESS ABOUT DISEASES AND RISING APPLICATIONS OF ULTRASOUND TO BOOST MARKET
12.4.6.1
INCREASING HEALTHCARE SPENDING TO PROPEL MARKET
12.4.7
REST OF ASIA PACIFIC
12.5.1
LATIN AMERICA: MACROECONOMIC OUTLOOK
12.5.2.1
FAVORABLE DEMOGRAPHIC CONDITIONS AND COVERAGE POLICIES TO PROPEL MARKET
12.5.3.1
GROWING ADOPTION OF ADVANCED DIAGNOSTIC IMAGING SYSTEMS TO DRIVE MARKET
12.5.4
REST OF LATIN AMERICA
12.6
MIDDLE EAST & AFRICA
12.6.1
MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
12.6.2.1
INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES, DIABETES, AND HYPERTENSION TO SUPPORT GROWTH
12.6.3
REST OF MIDDLE EAST & AFRICA
13
COMPETITIVE LANDSCAPE
Discover top strategies and market shares shaping the vascular imaging competitive landscape.
182
13.2
KEY PLAYER STRATEGY/RIGHT TO WIN
13.2.1
OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN VASCULAR IMAGING MARKET
13.3
REVENUE ANALYSIS, 2021–2024
13.4
MARKET SHARE ANALYSIS, 2024
13.5
COMPANY VALUATION AND FINANCIAL METRICS
13.6
BRAND/PRODUCT COMPARISON
13.7
COMPANY EVALUATION MATRIX: VASCULAR IMAGING MARKET, 2024
13.7.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
13.7.5.1
COMPANY FOOTPRINT
13.7.5.2
REGION FOOTPRINT
13.7.5.3
PRODUCT FOOTPRINT
13.7.5.4
APPLICATION FOOTPRINT
13.7.5.5
END-USER FOOTPRINT
13.8
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
13.8.1
PROGRESSIVE COMPANIES
13.8.2
RESPONSIVE COMPANIES
13.8.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
13.8.5.1
DETAILED LIST OF KEY STARTUPS/SMES
13.8.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
13.9
COMPETITIVE SCENARIO
13.9.1
PRODUCT LAUNCHES, UPGRADES, AND APPROVALS
14
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
201
14.1.1
SIEMENS HEALTHINEERS AG
14.1.1.1
BUSINESS OVERVIEW
14.1.1.2
PRODUCTS OFFERED
14.1.1.3
RECENT DEVELOPMENTS
14.1.3
FUJIFILM CORPORATION
14.1.4
PHILIPS HEALTHCARE
14.1.5
SHIMADZU CORPORATION
14.1.6
UNITED IMAGING HEALTHCARE CO., LTD
14.1.7
SAMSUNG HEALTHCARE
14.1.8
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
14.1.9
CANON MEDICAL SYSTEMS CORPORATION
14.1.10
KONICA MINOLTA, INC.
14.1.11
NEUSOFT CORPORATION
14.1.12
TERUMO CORPORATION
14.1.14
BRACCO IMAGING S.P.A.
14.1.17
NIPRO EUROPE GROUP COMPANIES
14.2.2
CHISON MEDICAL TECHNOLOGIES CO., LTD.
14.2.3
SONOSCAPE MEDICAL CORP.
14.2.6
HEALCERION CO., LTD.
14.2.8
BEIJING WEMED MEDICAL EQUIPMENT
15.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.3
CUSTOMIZATION OPTIONS
TABLE 1
VASCULAR IMAGING MARKET: INCLUSIONS AND EXCLUSIONS
TABLE 2
VASCULAR IMAGING MARKET: RISK ANALYSIS
TABLE 3
TECHNOLOGICAL ADVANCEMENTS IN VASCULAR IMAGING SYSTEMS
TABLE 4
VASCULAR IMAGING MARKET: UNMET NEEDS
TABLE 5
STRATEGIC MOVES BY KEY COMPANIES IN VASCULAR IMAGING MARKET
TABLE 6
VASCULAR IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 7
REGIONAL PRICING ANALYSIS OF KEY VASCULAR IMAGING MODALITIES, 2024 (USD)
TABLE 8
REGIONAL PRICING ANALYSIS OF KEY DIAGNOSTIC IMAGING MODALITIES, 2024 (USD)
TABLE 9
IMPORT DATA FOR COMPUTED TOMOGRAPHY SYSTEMS, 2020–2024 (HS CODE 902212)
TABLE 10
EXPORT DATA FOR COMPUTED TOMOGRAPHY SYSTEMS (HS CODE 902212), BY COUNTRY, 2020–2024 (USD THOUSAND)
TABLE 11
IMPORT DATA FOR ULTRASOUND SYSTEMS (HS CODE 901812), BY COUNTRY, 2020–2024 (USD THOUSAND)
TABLE 12
EXPORT DATA FOR ULTRASOUND SYSTEMS (HS CODE 901812), BY COUNTRY, 2020–2024 (USD THOUSAND)
TABLE 13
IMPORT DATA FOR MAGNETIC RESONANCE IMAGING SYSTEMS (HS CODE 901813), BY COUNTRY, 2020–2024 (USD THOUSAND)
TABLE 14
EXPORT DATA FOR MAGNETIC RESONANCE IMAGING SYSTEMS (HS CODE 901813), BY COUNTRY, 2020–2024 (USD THOUSAND)
TABLE 15
IMPORT DATA FOR X-RAY SYSTEMS (HS CODE 902214), BY COUNTRY, 2020–2024 (USD THOUSAND)
TABLE 16
EXPORT DATA FOR X-RAY SYSTEMS (HS CODE 902214), BY COUNTRY, 2020–2024 (USD THOUSAND)
TABLE 17
VASCULAR IMAGING MARKET: KEY CONFERENCES AND EVENTS, 2025–2026
TABLE 18
CASE STUDY: MAINTAINING STRONG FOCUS ON TECHNOLOGICAL INNOVATION AND ADDRESSING REGULATORY COMPLIANCE
TABLE 19
US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 20
CASE STUDY: AI-ASSISTED INTRAVASCULAR IMAGING FOR PRECISION ANGIOPLASTY
TABLE 21
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
TABLE 22
US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 23
US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
TABLE 24
CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
TABLE 25
JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
TABLE 26
CHINA: CLASSIFICATION OF MEDICAL DEVICES
TABLE 27
INDUSTRY STANDARDS FOR VASCULAR IMAGING MARKET
TABLE 28
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER (%)
TABLE 29
KEY BUYING CRITERIA, BY END USER
TABLE 30
VASCULAR IMAGING MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 31
VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY REGION, 2023–2030 (USD MILLION)
TABLE 32
VASCULAR IMAGING MARKET FOR ULTRASOUND, BY REGION, 2023–2030 (USD MILLION)
TABLE 33
VASCULAR IMAGING MARKET FOR DUPLEX ULTRASOUND, BY REGION, 2023–2030 (USD MILLION)
TABLE 34
VASCULAR IMAGING MARKET FOR DOPPLER ULTRASOUND, BY REGION, 2023–2030 (USD MILLION)
TABLE 35
VASCULAR IMAGING MARKET FOR MRI, BY REGION, 2023–2030 (USD MILLION)
TABLE 36
VASCULAR IMAGING MARKET FOR X-RAY SYSTEMS, BY REGION, 2023–2030 (USD MILLION)
TABLE 37
VASCULAR IMAGING MARKET FOR NUCLEAR IMAGING SYSTEMS, BY REGION, 2023–2030 (USD MILLION)
TABLE 38
VASCULAR IMAGING MARKET FOR CT SCANNERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 39
VASCULAR IMAGING MARKET FOR OPTICAL COHERENCE TOMOGRAPHY, BY REGION, 2023–2030 (USD MILLION)
TABLE 40
VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY REGION, 2023–2030 (USD MILLION)
TABLE 41
VASCULAR IMAGING MARKET FOR ACCESSORIES & CONSUMABLES, BY REGION, 2023–2030 (USD MILLION)
TABLE 42
VASCULAR IMAGING MARKET FOR STRAIN IMAGING, BY REGION, 2023–2030 (USD MILLION)
TABLE 43
VASCULAR IMAGING MARKET FOR HIGH SPATIAL AND TEMPORAL RESOLUTION, BY REGION, 2023–2030 (USD MILLION)
TABLE 44
VASCULAR IMAGING MARKET FOR AUTOMATED VESSEL MORPHOLOGY ASSESSMENT, BY REGION, 2023–2030 (USD MILLION)
TABLE 45
VASCULAR IMAGING MARKET FOR STREAMLINED PROCEDURAL WORKFLOW, BY REGION, 2023–2030 (USD MILLION)
TABLE 46
VASCULAR IMAGING MARKET FOR OTHER SOFTWARE & SERVICES, BY REGION, 2023–2030 (USD MILLION)
TABLE 47
VASCULAR IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 48
VASCULAR IMAGING MARKET FOR ATHEROSCLEROSIS, BY REGION, 2023–2030 (USD MILLION)
TABLE 49
VASCULAR IMAGING MARKET FOR ANEURYSM, BY REGION, 2023–2030 (USD MILLION)
TABLE 50
VASCULAR IMAGING MARKET FOR VASCULITIS, BY REGION, 2023–2030 (USD MILLION)
TABLE 51
VASCULAR IMAGING MARKET FOR DEEP VEIN THROMBOSIS, BY REGION, 2023–2030 (USD MILLION)
TABLE 52
VASCULAR IMAGING MARKET FOR ARTERIOVENOUS MALFORMATIONS & FISTULAS, BY REGION, 2023–2030 (USD MILLION)
TABLE 53
VASCULAR IMAGING MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
TABLE 54
VASCULAR IMAGING MARKET, BY END USER, BY TYPE, 2023–2030 (USD MILLION)
TABLE 55
VASCULAR IMAGING MARKET FOR HOSPITALS, BY REGION, 2023–2030 (USD MILLION)
TABLE 56
VASCULAR IMAGING MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 57
VASCULAR IMAGING MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 58
VASCULAR IMAGING MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 59
VASCULAR IMAGING MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 60
NUMBER OF IMAGING TESTS IN UK, 2022–2025
TABLE 61
NUMBER OF MRI UNITS PER COUNTRY, 2022–2024
TABLE 62
NORTH AMERICA: MACROECONOMIC OUTLOOK
TABLE 63
NORTH AMERICA: VASCULAR IMAGING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 64
NORTH AMERICA: VASCULAR IMAGING MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 65
NORTH AMERICA: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 66
NORTH AMERICA: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE, 2023–2030 (USD MILLION)
TABLE 67
NORTH AMERICA: VASCULAR IMAGING MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 68
NORTH AMERICA: VASCULAR IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 69
NORTH AMERICA: VASCULAR IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 70
US: VASCULAR IMAGING MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 71
US: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 72
US: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE, 2023–2030 (USD MILLION)
TABLE 73
CANADA: VASCULAR IMAGING MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 74
CANADA: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 75
CANADA: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE, 2023–2030 (USD MILLION)
TABLE 76
EUROPE: MACROECONOMIC OUTLOOK
TABLE 77
EUROPE: VASCULAR IMAGING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 78
EUROPE: VASCULAR IMAGING MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 79
EUROPE: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 80
EUROPE: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE, 2023–2030 (USD MILLION)
TABLE 81
EUROPE: VASCULAR IMAGING MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 82
EUROPE: VASCULAR IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 83
EUROPE: VASCULAR IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 84
GERMANY: VASCULAR IMAGING MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 85
GERMANY: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 86
GERMANY: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE, 2023–2030 (USD MILLION)
TABLE 87
UK: VASCULAR IMAGING MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 88
UK: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 89
UK: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE, 2023–2030 (USD MILLION)
TABLE 90
FRANCE: VASCULAR IMAGING MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 91
FRANCE: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 92
FRANCE: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE, 2023–2030 (USD MILLION)
TABLE 93
ITALY: VASCULAR IMAGING MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 94
ITALY: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 95
ITALY: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE, 2023–2030 (USD MILLION)
TABLE 96
SPAIN: VASCULAR IMAGING MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 97
SPAIN: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 98
SPAIN: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE, 2023–2030 (USD MILLION)
TABLE 99
REST OF EUROPE: VASCULAR IMAGING MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 100
REST OF EUROPE: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 101
REST OF EUROPE: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE, 2023–2030 (USD MILLION)
TABLE 102
ASIA PACIFIC: MACROECONOMIC INDICATORS
TABLE 103
ASIA PACIFIC: VASCULAR IMAGING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 104
ASIA PACIFIC: VASCULAR IMAGING MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 105
ASIA PACIFIC: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 106
ASIA PACIFIC: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE, 2023–2030 (USD MILLION)
TABLE 107
ASIA PACIFIC: VASCULAR IMAGING MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 108
ASIA PACIFIC: VASCULAR IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 109
ASIA PACIFIC: VASCULAR IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 110
JAPAN: VASCULAR IMAGING MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 111
JAPAN: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 112
JAPAN: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE, 2023–2030 (USD MILLION)
TABLE 113
CHINA: VASCULAR IMAGING MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 114
CHINA: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 115
CHINA: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE, 2023–2030 (USD MILLION)
TABLE 116
INDIA: VASCULAR IMAGING MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 117
INDIA: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 118
INDIA: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE, 2023–2030 (USD MILLION)
TABLE 119
SOUTH KOREA: VASCULAR IMAGING MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 120
SOUTH KOREA: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 121
SOUTH KOREA: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE, 2023–2030 (USD MILLION)
TABLE 122
AUSTRALIA: VASCULAR IMAGING MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 123
AUSTRALIA: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 124
AUSTRALIA: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE, 2023–2030 (USD MILLION)
TABLE 125
REST OF ASIA PACIFIC: VASCULAR IMAGING MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 126
REST OF ASIA PACIFIC: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 127
REST OF ASIA PACIFIC: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE, 2023–2030 (USD MILLION)
TABLE 128
LATIN AMERICA: MACROECONOMIC OUTLOOK
TABLE 129
LATIN AMERICA: VASCULAR IMAGING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 130
LATIN AMERICA: VASCULAR IMAGING MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 131
LATIN AMERICA: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 132
LATIN AMERICA: ULTRASOUND MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 133
LATIN AMERICA: VASCULAR IMAGING MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 134
LATIN AMERICA: VASCULAR IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 135
LATIN AMERICA: VASCULAR IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 136
BRAZIL: VASCULAR IMAGING MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 137
BRAZIL: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 138
BRAZIL: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE, 2023–2030 (USD MILLION)
TABLE 139
MEXICO: VASCULAR IMAGING MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 140
MEXICO: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 141
MEXICO: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE, 2023–2030 (USD MILLION)
TABLE 142
REST OF LATIN AMERICA: VASCULAR IMAGING MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 143
REST OF LATIN AMERICA: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 144
REST OF LATIN AMERICA: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE, 2023–2030 (USD MILLION)
TABLE 145
MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
TABLE 146
MIDDLE EAST & AFRICA: VASCULAR IMAGING MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 147
MIDDLE EAST & AFRICA: VASCULAR IMAGING MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 148
MIDDLE EAST & AFRICA: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 149
MIDDLE EAST & AFRICA: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE, 2023–2030 (USD MILLION)
TABLE 150
MIDDLE EAST & AFRICA: VASCULAR IMAGING MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 151
MIDDLE EAST & AFRICA: VASCULAR IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 152
MIDDLE EAST & AFRICA: VASCULAR IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 153
GCC COUNTRIES: VASCULAR IMAGING MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 154
GCC COUNTRIES: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 155
GCC COUNTRIES: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE, 2023–2030 (USD MILLION)
TABLE 156
REST OF MIDDLE EAST & AFRICA: VASCULAR IMAGING MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 157
REST OF MIDDLE EAST & AFRICA: SYSTEMS AND CONSOLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 158
REST OF MIDDLE EAST & AFRICA: ULTRASOUND MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 159
OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN VASCULAR IMAGING MARKET, JANUARY 2022–OCTOBER 2025
TABLE 160
VASCULAR IMAGING MARKET: DEGREE OF COMPETITION
TABLE 161
VASCULAR IMAGING MARKET: REGION FOOTPRINT
TABLE 162
VASCULAR IMAGING MARKET: PRODUCT TYPE FOOTPRINT (1/2)
TABLE 163
VASCULAR IMAGING MARKET: PRODUCT TYPE FOOTPRINT (2/2)
TABLE 164
VASCULAR IMAGING MARKET: APPLICATION FOOTPRINT
TABLE 165
VASCULAR IMAGING MARKET: END-USER FOOTPRINT
TABLE 166
VASCULAR IMAGING MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 167
VASCULAR IMAGING MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, BY REGION
TABLE 168
VASCULAR IMAGING MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, BY PRODUCT TYPE
TABLE 169
VASCULAR IMAGING MARKET: PRODUCT LAUNCHES, UPGRADES, AND APPROVALS, JANUARY 2022–AUGUST 2025
TABLE 170
VASCULAR IMAGING MARKET: DEALS, JANUARY 2022–AUGUST 2025
TABLE 171
VASCULAR IMAGING MARKET: EXPANSIONS, JANUARY 2022–AUGUST 2025
TABLE 172
SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
TABLE 173
SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED
TABLE 174
SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2022–AUGUST 2025
TABLE 175
SIEMENS HEALTHINEERS AG: EXPANSIONS, JANUARY 2022–AUGUST 2025
TABLE 176
GE HEALTHCARE: COMPANY OVERVIEW
TABLE 177
GE HEALTHCARE: PRODUCTS OFFERED
TABLE 178
GE HEALTHCARE: PRODUCT LAUNCHES, UPGRADES, AND APPROVALS, JANUARY 2022–AUGUST 2025
TABLE 179
GE HEALTHCARE: DEALS, JANUARY 2022–AUGUST 2025
TABLE 180
GE HEALTHCARE: EXPANSIONS, JANUARY 2022–AUGUST 2025
TABLE 181
FUJIFILM CORPORATION: COMPANY OVERVIEW
TABLE 182
FUJIFILM CORPORATION: PRODUCTS OFFERED
TABLE 183
FUJIFILM CORPORATION: PRODUCT LAUNCHES, UPGRADES, AND APPROVALS, JANUARY 2022–AUGUST 2025
TABLE 184
FUJIFILM CORPORATION: DEALS, JANUARY 2022–AUGUST 2025
TABLE 185
FUJIFILM CORPORATION: EXPANSIONS, JANUARY 2022–AUGUST 2025
TABLE 186
PHILIPS HEALTHCARE: COMPANY OVERVIEW
TABLE 187
PHILIPS HEALTHCARE: PRODUCTS OFFERED
TABLE 188
PHILIPS HEALTHCARE: PRODUCT LAUNCHES, UPGRADES, AND APPROVALS, JANUARY 2022–AUGUST 2025
TABLE 189
PHILIPS HEALTHCARE: DEALS, JANUARY 2022–AUGUST 2025
TABLE 190
PHILIPS HEALTHCARE: EXPANSIONS, JANUARY 2022–AUGUST 2025
TABLE 191
SHIMADZU CORPORATION: COMPANY OVERVIEW
TABLE 192
SHIMADZU CORPORATION: PRODUCTS OFFERED
TABLE 193
SHIMADZU CORPORATION: DEALS, JANUARY 2022–AUGUST 2025
TABLE 194
UNITED IMAGING HEALTHCARE CO., LTD: COMPANY OVERVIEW
TABLE 195
UNITED IMAGING HEALTHCARE CO., LTD: PRODUCTS OFFERED
TABLE 196
UNITED IMAGING HEALTHCARE CO., LTD: PRODUCT LAUNCHES, UPGRADES, AND APPROVALS, JANUARY 2022–AUGUST 2025
TABLE 197
UNITED IMAGING HEALTHCARE CO., LTD: DEALS, JANUARY 2022–AUGUST 2025
TABLE 198
UNITED IMAGING HEALTHCARE CO., LTD: EXPANSIONS, JANUARY 2022–AUGUST 2025
TABLE 199
SAMSUNG HEALTHCARE: COMPANY OVERVIEW
TABLE 200
SAMSUNG HEALTHCARE: PRODUCTS OFFERED
TABLE 201
SAMSUNG HEALTHCARE: PRODUCT LAUNCHES, UPGRADES, AND APPROVALS, JANUARY 2022–AUGUST 2025
TABLE 202
SAMSUNG HEALTHCARE: DEALS, JANUARY 2022–AUGUST 2025
TABLE 203
SAMSUNG HEALTHCARE: OTHER DEVELOPMENTS, JANUARY 2022–AUGUST 2025
TABLE 204
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW
TABLE 205
SHEZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCTS OFFERED
TABLE 206
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCT LAUNCHES, UPGRADES, AND APPROVALS, JANUARY 2022–AUGUST 2025
TABLE 207
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: DEALS, JANUARY 2022–AUGUST 2025
TABLE 208
CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW
TABLE 209
CANON MEDICAL SYSTEMS CORPORATION: PRODUCTS OFFERED
TABLE 210
CANON MEDICAL SYSTEMS CORPORATION: PRODUCT LAUNCHES, UPGRADES, AND APPROVALS, JANUARY 2022–AUGUST 2025
TABLE 211
CANON MEDICAL SYSTEMS CORPORATION: DEALS, JANUARY 2022–AUGUST 2025
TABLE 212
CANON MEDICAL SYSTEMS CORPORATION: EXPANSIONS, JANUARY 2022–AUGUST 2025
TABLE 213
KONICA MINOLTA, INC.: COMPANY OVERVIEW
TABLE 214
KONICA MINOLTA, INC.: PRODUCTS OFFERED
TABLE 215
NEUSOFT CORPORATION: COMPANY OVERVIEW
TABLE 216
NEUSOFT CORPORATION: PRODUCTS OFFERED
TABLE 217
NEUSOFT CORPORATION: PRODUCT LAUNCHES, UPGRADES, AND APPROVALS, JANUARY 2022–AUGUST 2024
TABLE 218
TERUMO CORPORATION: COMPANY OVERVIEW
TABLE 219
TERUMO CORPORATION: PRODUCTS OFFERED
TABLE 220
HOLOGIC, INC.: COMPANY OVERVIEW
TABLE 221
HOLOGIC, INC.: PRODUCTS OFFERED
TABLE 222
HOLOGIC, INC.: DEALS, JANUARY 2022–AUGUST 2025
TABLE 223
HOLOGIC, INC.: EXPANSIONS, JANUARY 2022–AUGUST 2025
TABLE 224
BRACCO IMAGING S.P.A.: COMPANY OVERVIEW
TABLE 225
BRACCO IMAGING S.P.A.: PRODUCTS OFFERED
TABLE 226
BRACCO IMAGING S.P.A.: DEALS, JANUARY 2022–AUGUST 2025
TABLE 227
BRACCO IMAGING S.P.A.: EXPANSIONS, JANUARY 2022–AUGUST 2025
TABLE 228
BAYER AG: COMPANY OVERVIEW
TABLE 229
BAYER AG: PRODUCTS OFFERED
TABLE 230
BAYER AG: DEALS, JANUARY 2022–AUGUST 2025
TABLE 231
BAYER AG: EXPANSION, JANUARY 2022–AUGUST 2025
TABLE 232
GUERBET: COMPANY OVERVIEW
TABLE 233
GUERBET: PRODUCTS OFFERED
TABLE 234
NIPRO EUROPE GROUP COMPANIES: COMPANY OVERVIEW
TABLE 235
NIPRO EUROPE GROUP COMPANIES: PRODUCTS OFFERED
TABLE 236
ACCUVEIN, INC.: COMPANY OVERVIEW
TABLE 237
CHISON MEDICAL TECHNOLOGIES CO., LTD.: COMPANY OVERVIEW
TABLE 238
SONOSCAPE MEDICAL CORP.: COMPANY OVERVIEW
TABLE 239
PIUR IMAGING: COMPANY OVERVIEW
TABLE 240
ARINETA LTD: COMPANY OVERVIEW
TABLE 241
HEALCERION CO., LTD.: COMPANY OVERVIEW
TABLE 242
ECHONOUS INC.: COMPANY OVERVIEW
TABLE 243
BEIJING WEMED MEDICAL EQUIPMENT: COMPANY OVERVIEW
TABLE 244
CLARIUS: COMPANY OVERVIEW
TABLE 245
ESAOTE SPA: COMPANY OVERVIEW
FIGURE 1
VASCULAR IMAGING MARKET SEGMENTATION AND REGIONAL SCOPE
FIGURE 3
KEY SECONDARY SOURCES
FIGURE 5
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 6
BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 7
RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 8
MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION)
FIGURE 9
MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
FIGURE 10
TOP-DOWN APPROACH
FIGURE 11
GLOBAL MARKET GROWTH PROJECTIONS
FIGURE 12
DATA TRIANGULATION METHODOLOGY
FIGURE 13
VASCULAR IMAGING MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
FIGURE 14
VASCULAR IMAGING MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
FIGURE 15
VASCULAR IMAGING MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 16
GROWING PREVALENCE OF CARDIOVASCULAR DISEASES TO DRIVE MARKET
FIGURE 17
HOSPITALS SEGMENT AND US LED NORTH AMERICAN MARKET IN 2025
FIGURE 18
CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 19
VASCULAR IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 20
VASCULAR IMAGING MARKET: PORTER’S FIVE FORCES
FIGURE 21
VASCULAR IMAGING MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 22
VASCULAR IMAGING MARKET: VALUE CHAIN ANALYSIS
FIGURE 23
ECOSYSTEM ANALYSIS
FIGURE 24
IMPORT SCENARIO FOR COMPUTED TOMOGRAPHY SYSTEMS (HS CODE 902212), 2020–2024 (USD THOUSAND)
FIGURE 25
EXPORT SCENARIO FOR COMPUTED TOMOGRAPHY SYSTEMS (HS CODE 902212), 2020–2024 (USD THOUSAND)
FIGURE 26
IMPORT SCENARIO FOR ULTRASOUND SYSTEMS (HS CODE 901812), 2020–2024 (USD THOUSAND)
FIGURE 27
EXPORT SCENARIO FOR ULTRASOUND SYSTEMS (HS CODE 901812), 2020–2024 (USD THOUSAND)
FIGURE 28
IMPORT SCENARIO FOR MAGNETIC RESONANCE IMAGING SYSTEMS (HS CODE 901813), 2020–2024 (USD THOUSAND)
FIGURE 29
EXPORT SCENARIO FOR MAGNETIC RESONANCE IMAGING SYSTEMS (HS CODE 901813), 2020–2024 (USD THOUSAND)
FIGURE 30
IMPORT SCENARIO FOR X-RAY SYSTEMS (HS CODE 902214), 2020–2024 (USD THOUSAND)
FIGURE 31
EXPORT SCENARIO FOR X-RAY SYSTEMS (HS CODE 902214), 2020–2024 (USD THOUSAND)
FIGURE 32
VASCULAR IMAGING MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 33
INVESTMENT AND FUNDING SCENARIO, 2019–2023
FIGURE 34
NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023
FIGURE 35
VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 (USD MILLION)
FIGURE 36
TOP 10 PATENT APPLICANTS FOR CT SCANNERS, JANUARY 2015–NOVEMBER 2025
FIGURE 37
TOP 10 PATENT APPLICANTS FOR MRI SYSTEMS, JANUARY 2015–NOVEMBER 2025
FIGURE 38
TOP 10 PATENT APPLICANTS FOR ULTRASOUND IMAGING SYSTEMS, JANUARY 2015– NOVEMBER 2025
FIGURE 39
TOP 10 PATENT APPLICANTS FOR X-RAY IMAGING SYSTEMS, JANUARY 2015– NOVEMBER 2025
FIGURE 40
TOP 10 PATENT APPLICANTS FOR NUCLEAR IMAGING SYSTEMS, JANUARY 2015–DECEMBER 2025
FIGURE 41
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP FOUR END USERS
FIGURE 42
KEY BUYING CRITERIA, BY END USER
FIGURE 43
NORTH AMERICA: VASCULAR IMAGING MARKET SNAPSHOT
FIGURE 44
ASIA PACIFIC: VASCULAR IMAGING MARKET SNAPSHOT
FIGURE 45
REVENUE ANALYSIS OF KEY PLAYERS IN VASCULAR IMAGING MARKET, 2021–2024 (USD BILLION)
FIGURE 46
MARKET SHARE ANALYSIS OF KEY PLAYERS IN VASCULAR IMAGING MARKET, 2024
FIGURE 47
RANKING OF KEY PLAYERS IN VASCULAR IMAGING MARKET, 2024
FIGURE 48
EV/EBITDA OF KEY VENDORS
FIGURE 49
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 50
VASCULAR IMAGING MARKET: BRAND/PRODUCT COMPARISON
FIGURE 51
VASCULAR IMAGING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 52
VASCULAR IMAGING MARKET: COMPANY FOOTPRINT
FIGURE 53
VASCULAR IMAGING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 54
SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2024)
FIGURE 55
GE HEALTHCARE: COMPANY SNAPSHOT (2024)
FIGURE 56
FUJIFILM CORPORATION: COMPANY SNAPSHOT (2024)
FIGURE 57
PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2024)
FIGURE 58
SHIMADZU CORPORATION: COMPANY SNAPSHOT (2024)
FIGURE 59
UNITED IMAGING HEALTHCARE CO., LTD: COMPANY SNAPSHOT (2024)
FIGURE 60
SAMSUNG HEALTHCARE: COMPANY SNAPSHOT (2024)
FIGURE 61
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY SNAPSHOT (2023)
FIGURE 62
CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT (2024)
FIGURE 63
KONICA MINOLTA, INC.: COMPANY SNAPSHOT (2024)
FIGURE 64
NEUSOFT CORPORATION: COMPANY SNAPSHOT (2024)
FIGURE 65
TERUMO CORPORATION: COMPANY SNAPSHOT (2024)
FIGURE 66
HOLOGIC, INC.: COMPANY SNAPSHOT (2023)
FIGURE 67
BAYER AG: COMPANY SNAPSHOT (2024)
FIGURE 68
GUERBET: COMPANY SNAPSHOT (2022)
Growth opportunities and latent adjacency in Vascular Imaging Market